Universidad Politecnica de Madrid (UPM)
The Artificial Intelligence (AI) Lab at the School of Computer Science, UPM (Universidad Politecnica de Madrid) is a non-profit, public, research laboratory dedicated to 3 main areas of R&D:
- Biomedical Informatics research (distributed databases, data mining, genetic workstation, guidelines and protocols, artificial intelligence in medicine, image processing)
- Artificial Intelligence (ontologies, machine learning, games, search models, knowledge representation and acquisition)
- Neural networks and DNA-based computing.
The laboratory was created in 1984 and during the last 15 years has obtained 3 international grants, from multinational companies such as XEROX and Hewlett-Packard. The laboratory has also participated in more than 15 EU-funded research projects. The Biomedical Informatics Group (B.I.G.) of the AI lab was established in 1993. The staff at the group includes one full professor, two associate professors, one assistant professor, ten external professors and researchers collaborating with the lab and around 15 graduate and undergraduate students. Collaborations include exchanges with foreign institutions, such as Harvard University (where six members of the lab have worked during the past years for mid-term and long-term stays), Georgia Tech and Rutgers University, in the USA, and research agreements with hospitals and health institutions in Spain. Contracts in biomedical informatics have included the Ministry of Defence, Spain, and industry, including funding from computer companies (E.g., HP), and from Spanish software companies. The BIG group has obtained various awards for excellence in research from the Spanish Society for Health Informatics and other institutions.
Prof. Víctor Maojo
Prof. Víctor Maojo is a Full Professor and Director, Biomedical Informatics Group, Artificial Intelligence Lab, UPM, Madrid. He holds a M.D. degree (medicine) and a Ph.D. in Computer Science. He has been a Postdoctoral Researcher in Georgia Tech (Atlanta, USA, 1990-91), and in the Decision Systems Group, Harvard University-MIT (Boston, USA, 1991-93). He has been an Expert for the European Commission in the IV, V, VI and VII Framework Programmes. He has participated in the IST study BIOINFOMED, the INFOGENMED and ACGT projects and the INFOBIOMED network of Excellence. He has been the Chairman of the 2nd International Symp. on Medical Data Analysis (ISMDA 2001).